April 22, 2025 3:25–3:45 PM
Strategy 1
Verdant Scientific is developing a first-in-class, first-in-approach small molecule for the treatment of atopic dermatitis, more commonly known as eczema, which is poised to completely change the treatment of this chronic, inflammatory skin condition, which affects over 200 million people worldwide.
Sponsors
